Hester Biosciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2371.65

-34.40 (-1.43%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2371.65

-34.40 (-1.43%)
15:41 Dec 20

Quality

82/100
High Financial Strength

Valuation

20/100
Expensive Valuation

Technical

47/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	214.33	235.01	266.09	304.55	312.2
Operating Expenses +	145.68	175.03	215.48	250.89	249.32
Raw Material	46.63	73.27	82.74	87.13	80.14
Increase Decrease in Cost	3.6	-10.56	-5.25	8.74	10
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	38.92	45.33	56.02	64.13	63.58
Miscellaneous Expenses	72.47	92.23	141.47	156.53	95.6
Operating Profit	68.65	59.98	50.61	53.66	62.88
Other Income	4.68	13.74	15.15	10.64	8.19
Depreciation	13.31	16.58	20.7	17.17	15.82
Interest	6.6	4.06	9.32	19.78	20.03
Profit before tax and exceptio..	53.42	53.08	35.74	27.34	35.22
Exceptional Items	-3.32	0	0	0	0
PBT	50.1	53.08	35.74	27.34	35.22
Provision for Taxation	15.4	14.02	12.12	10.79	12.45
Net Profit	34.7	39.06	23.63	16.56	22.79
NET Profit after MI	34.43	39.48	26.63	18.89	23.47
EPS	40.79	46.41	32.96	24.88	30.91
Operating Profit Margin (%)	32.03	25.52	19.02	17.62	20.14
Net Profit Margin (%)	16.06	16.8	10.01	6.2	7.52

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	53.70	53.70	53.70	53.70	53.70
FII	0.60	0.50	0.40	0.40	0.40
MF	0.00	0.00	0.00	0.00	0.00
Public	45.60	45.70	45.80	45.80	45.80
Others	0.10	0.10	0.10	0.10	0.10
Others	0.00	0.00	0.00	0.00	0.00